distribution of patients is one factor that contributes to the heterogeneity, because pediatric and adult epilepsy patients differ in many aspects. 8, 18 Some studies also included FCD combined with other lesions, such as hippocampal sclerosis or brain tumors, which usually have a better prognosis than FCD without combined lesions. 12 Therefore, a focused analysis of the surgical outcomes in pediatric patients with FCD that is not combined with other lesions is important for the understanding of this disease.
Epilepsy is a lifelong disease. 3 Long-term follow-up series have shown that the seizure-free rates after epilepsy surgery decline gradually. 35, 36 In contrast, a small proportion of patients with failed surgery spontaneously become seizure free after many years (the so-called running-down phenomenon). 27 Therefore, longitudinal analyses are highly recommended for the evaluation of epilepsy surgery outcomes. Studies based on cross-sectional analyses provide limited information on the long-lasting consequences of epilepsy surgery. We reported previously on the midterm surgical outcomes of 30 pediatric patients with FCD, based on the cross-sectional analyses. 24 That study also included patients who had FCD combined with a brain tumor.
In this study, we performed longitudinal analyses of the long-term surgical outcomes of 41 pediatric epilepsy patients with FCD that was not combined with other lesions. Actuarial seizure-free rates were calculated and clinical factors affecting the outcomes were analyzed.
Methods

Patient Population
Our operation database includes pediatric patients who underwent surgery for medically intractable epilepsy before the age of 18 years at the Seoul National University Children's Hospital from 1995 to the present. We searched the database for patients with a pathological diagnosis of FCD. We excluded patients who had FCD combined with hippocampal sclerosis or a brain tumor. We also excluded patients who underwent hemispherectomy for widespread lesions. A minimum postoperative follow-up of 2 years was required for inclusion. Forty-one consecutive patients were included in this study; 20 patients were male and 21 were female. The median age at surgery was 9 years (range 1-17 years). We reviewed the medical records of these patients retrospectively. We obtained information on the seizure characteristics, presurgical evaluation, surgery, surgical complications, follow-up and seizure outcome, AED discontinuation, and repeat operation in the patients from the medical records. This study was approved by the local institutional review board.
Statistical Analysis
Surgical outcomes were evaluated according to the Engel classification.
6 A seizure-free state (Engel Class Ia) was regarded as a good surgical outcome. The time of seizure recurrence was checked and the Engel class was measured every year. The Kaplan-Meier method was used to calculate actuarial seizure-free rates. A log-rank test and a Cox proportional hazards model were used for the determination of clinical variables that influenced the outcomes. The SPSS version 17.0 software (SPSS, Inc.) was used for statistical analyses. The significance level was set at 5%.
Results
Seizure Characteristics
The median age at seizure onset was 3 years (range 10 days-13 years). The median duration of epilepsy was 4 years (range 0.9-11 years). A history of febrile convulsion was noted in 5 patients (12%). Three patients (7%) had a previous infection in the CNS. Twenty patients (49%) had complex partial seizures, 18 (44%) had simple partial seizures, and 3 (7%) had both complex partial and simple partial seizures. Secondary generalization was observed in 34 patients (83%). Seizure frequency was daily in 21 patients (51%), weekly in 13 (32%), and monthly in 7 (17%). Seizures were medically intractable; that is, seizures were not adequately controlled by major AEDs in all patients. The patients received "add-on" AEDs for adequate seizure control. After seizure-control failure and the decision to proceed with surgical treatment, the aim of add-on therapy was the alleviation of seizures and prevention of status epilepticus until surgical treatment. The median number of AEDs taken by the patients at the time of surgery was 3 (range 1-6).
Presurgical Evaluation
Interictal surface EEG studies were obtained in all patients. Ictal surface EEG with video monitoring was performed in 40 patients (98%). A 1.5-T MR imaging study of the brain was obtained in all patients, and FDG-PET studies were performed in 37 patients (90%). Ictal Tc-HMPAO-SPECT was performed in 5 patients (12%). Neuropsychological testing was performed in 26 patients (63%). A Wada test was performed for the determination of hemispheric dominance in 3 patients (7%).
Interictal surface EEG studies were localized to a unilateral hemisphere in 32 patients (78%), to bilateral hemispheres in 3 patients (7%), and were nonlocalizable in 6 patients (15%). Ictal surface EEG studies were localized to a specific region in 32 (80%) of 40 patients, to bilateral hemispheres in 6 (15%), and were nonlocalizable in 2 (5%). The MR imaging studies revealed the presence of a lesion (lesional epilepsy) in 22 patients (54%), and 19 (46%) had no discernible lesions on MR imaging (nonlesional epilepsy). The FDG-PET scans showed hypometabolic regions in 34 (92%) of 37 patients. Ictal SPECT showed regions of increased perfusion in 26 (84%) of 31 patients. In the 22 patients with lesional epilepsy, concordance of presurgical evaluations was succinctly defined as the concordance of 3 evaluation modalities that were applied to more than 90% of the patients (MR imaging, surface ictal EEG, and FDG-PET). In the 19 patients with nonlesional epilepsy, concordance was defined as the concordance of surface ictal EEG and FDG-PET studies. Concordance of presurgical evaluation was documented in 9 (41%) of the 22 patients with lesional epilepsy and in 8 (42%) of the 19 patients with nonlesional epilepsy.
The syndromic diagnoses were frontal lobe epilepsy in 13 patients (32%), TLE in 12 (29%), occipital lobe epilepsy in 9 (22%), parietal lobe epilepsy in 4 (10%), and multilobar epilepsy in 3 (7%).
Invasive monitoring was performed in 36 patients (88%). Invasive EEG revealed an ictal onset zone in 35 patients, but failed to yield adequate results in 1 patient because of brain swelling after initiation of EEG monitoring.
Surgery Protocol
All patients underwent a cortical resection; this was performed in the frontal lobe in 14 patients, in the temporal lobe in 11, in the occipital lobe in 7, in the parietal lobe in 3, and in multiple lobes in 6 patients. Cortical resection was combined with MST in 3 patients. For lesional epilepsy, a complete resection was defined as removal of the preexisting lesion and ictal onset zones identified using invasive monitoring. For nonlesional epilepsy, complete resection was defined as removal of the entire ictal onset zone identified. 19 If localization of an ictal onset zone was widespread on invasive monitoring, or MST was combined with cortical resection, the resection was considered incomplete. Among the 22 patients with lesional epilepsy, the resection was incomplete in 4 (in 2 patients there was involvement of the eloquent areas and there was a residual margin in the other 2). Among the 19 patients with nonlesional epilepsy, the resection was incomplete in 7 (presence of widespread ictal onset zones in 2 patients, involvement of an eloquent area in 3, and a residual margin in the remaining 2).
Surgical specimens were fixed in formalin and paraffinized for pathological examination. Slides of pathological specimens were reviewed by a neuropathologist (S.H.P.) and were classified according to Palmini et al. 23 Type 1 FCD was found in 22 patients (54%); 8 patients (20%) had Type 2a FCD; and 11 (27%) had Type 2b FCD.
Surgical Complications
Postoperatively, hemiparesis developed in 6 patients (4 had complete recovery, but fine motor deficits remained in the affected hand in 2 patients). Monoparesis developed in 3 patients (2 had complete recovery, but 1 patient had a fine motor deficit in the affected hand). Transient sensory deficit (loss of proprioception) was observed in 1 patient. Transient third nerve palsy was observed in 1 patient. One patient had a permanent superior quadrantanopia, but it was not a disabling deficit. One patient had postoperative subdural hematoma that required emergency evacuation; this patient had no neurological sequelae. Brain abscess developed in 1 patient, which was resolved by antibiotic administration without neurological sequelae.
Follow-Up Protocol
After surgery, changes in seizure frequency and pattern were checked in the outpatient clinic. Antiepileptic drugs were prescribed to the patients, as had been done preoperatively. However, modifications of the regimen for withdrawal of more toxic and less effective AEDs were made shortly after surgery. The tapering and discontinuation of AEDs was highly individualized, and took into consideration the preoperative seizure frequency, postoperative neuroimaging and EEG findings, and the developmental performance of the patients. The mean follow-up period was 73 months (range 24-153 months).
Seizure Outcome
A Kaplan-Meier survival plot showed that seizurefree rates after surgery dropped rapidly within 3 months, which reflected a lack of remission of seizures rather than early recurrence of seizures (Fig. 1) . The actuarial seizure-free rate was 51% at 3 months postoperatively. After 3 months, the seizure-free rate declined gradually until 3 years postoperatively. The actuarial seizure-free rates were 49, 44, and 33% in the 1st, 2nd, and 5th postoperative years, respectively. After 3 years, there was no decline in the seizure-free rate.
Univariate analyses on dichotomous variables performed using the Kaplan-Meier method and a log-rank test revealed that the absence of a lesion on MR imaging (p = 0.037), and incomplete resection (p < 0.001) were significantly associated with poor seizure control (Fig. 2) . Female sex was marginally associated with poor seizure control (p = 0.068), but it was significantly associated with nonlesional epilepsy (p = 0.008, chi-square test): two-thirds of the female patients (14 [67%] of 21) had nonlesional epilepsy, whereas three-quarters of the male patients (15 [75%] of 20) had lesional epilepsy. A lack of concordance among localization data obtained from MR imaging, surface ictal EEG, and FDG-PET studies was also marginally associated with poor seizure control in patients with lesional epilepsy (p = 0.076), but the lack of concordance of surface ictal EEG and FDG-PET studies was an insignificant variable in patients with nonlesional epilepsy (p = 0.678). Pathological types (Palmini Types 1, 2a, and 2b) were not significant variables that affected seizure outcomes (p = 0.170), but showed a trend toward Long-term follow-up of the 26 patients who had seizure recurrence after surgery showed that 3 patients spontaneously became seizure free at 14, 56, and 65 months, respectively, after the first postoperative seizure. Thereafter, these 3 patients were seizure free for at least 2 years (105, 24, and 46 months, respectively), which corresponded to Engel Class Ic. The actuarial rate of this running-down phenomenon was 10% in the 5th year from the first postoperative seizure (Fig. 3) . The running-down phenomenon was independent of their medications in 2 patients. One patient became seizure free after the addition of pregabalin to a multidrug regimen of oxcarbazepine and topiramate at 86 months after surgery.
Discontinuation of AEDs
Among the 15 patients who became seizure free after surgery, 13 were free of AEDs at their last follow-up. The median time to AED discontinuation was 23 months (95% CI 17-29 months). The actuarial rates of AED discontinuation were 27% in the 1st year, 55% in the 2nd year, and 91% in the 5th year (Fig. 4) . The 3 patients who became seizure free as a result of the running-down phenomenon were still receiving AEDs, although more than 2 years had elapsed from the last seizure occurrence in these patients.
Repeat Operations
A repeat operation was attempted in 4 patients in whom seizure control failed. Three patients received additional cortical resection after the second invasive monitoring, and 1 patient received vagal nerve stimulation for palliation. One patient became seizure free after an additional cortical resection. Therefore, 19 patients (46%) were seizure free at their last follow-up visit: 15 patients were seizure free after the initial surgery, 3 patients as a result of the running-down phenomenon, and 1 patient after a repeat operation. At their last follow-up, 5 patients (12%) were Engel Class II, 7 (17%) were Engel Class III, and 10 (24%) corresponded to Engel Class IV.
Discussion
The outcomes of epilepsy surgery in children have improved greatly over recent decades. Thorough invasive electrophysiological monitoring, application of novel imaging modalities, and advanced surgical techniques, such as the use of neuronavigation, render epilepsy surgery a powerful solution for carefully selected children plagued with uncontrolled seizures. However, intractable epilepsy associated with FCD remains a challenging disease. Seizure-free rates presented in recently published series from children's and general hospitals after surgery in patients with FCD were approximately 50%. 4, 11, 17, 18 This means that roughly half of the surgical candidates selected based on well-organized processes by experienced professionals were not seizure free after the operation, even though a substantial proportion of these patients had a worthwhile improvement in seizure frequency after surgery. Our results also showed that the actuarial seizure-free rate in the 1st year was 49%. However, the actuarial seizure-free rates thereafter diminished gradually, down to 33% in the 3rd year after surgery. Long-term follow-up studies on epilepsy surgery outcomes reported gradual seizure recurrence and a decline in seizure-free rates. 22, 30, 36 It was reported that, among patients who were seizure free in the 1st year postoperatively, in 44% of cases they experienced seizure recurrence thereafter. 36 All of these studies included mainly patients with TLE, notably caused by hippocampal sclerosis. Few studies have addressed the longitudinal changes in seizure outcomes for FCD, especially in children. Seizure recurrence after years of remission after epilepsy surgery remains an enigmatic phenomenon. A widespread cortical pathological entity is believed to be the principal cause of this phenomenon.
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In this regard, patients with FCD appear to be more vulnerable to seizure recurrence than do patients with mesial temporal lesions or brain tumors. Deprivation of the protective effects of AEDs is considered to be another factor responsible for seizure recurrence.
28,36 Fig. 3 . A Kaplan-Meier plot demonstrating the cumulative incidence of late remission of seizures, the so-called running-down phenomenon, in 26 patients with initial seizure-control failure. The horizontal axis represents the time from the seizure recurrence after surgery to complete seizure remission. The actuarial rate of this running-down phenomenon was 10% in the 5th year from the first postoperative seizure. Fig. 4 . Among the 15 patients who became seizure free after surgery, 13 were eventually free of AEDs. The median time to AED discontinuation was 17 months. The actuarial rates of AED discontinuation were 27, 55, and 91% in the 1st, 2nd, and 5th postoperative years, respectively.
In our study, absence of a lesion on MR imaging and incomplete resection were significantly associated with seizure-control failure. Curiously, female sex showed a marginally significant association with seizure-control failure. There is a report that female sex was associated with poor outcome in epilepsy surgery. 34 However, in our study, the distribution of lesional epilepsy was uneven between the sexes, which may be the confounding factor. The presence of a lesion on MR imaging is known to be a strong prognostic factor for successful outcome in epilepsy surgery. 14, 16 Focal cortical dysplasia with balloon cells (Palmini Type 2b), which was originally described by Taylor et al., 32 is more likely to present as a lesion on MR imaging than is FCD of less disorganized varieties (for example, Palmini Type 1a). 23 A higher pathological grade of FCD is associated with a better surgical outcome. 17 In our study, we also observed the correlation between a higher pathological grade and lesional epilepsy. For lesional epilepsy, it is generally more feasible to define the extent of resection by combining information from neuroimaging and electrophysiological studies, which could lead to a more complete resection of the epileptogenic area.
Completeness of resection is another important prognostic factor for seizure freedom in many studies. 4, 7, 11, 17, 19 For lesional epilepsy, the definition of complete resection is straightforward. However, for nonlesional epilepsy, the completeness of resection is difficult to define objectively, and can sometimes be determined only by the results. Previous studies emphasizing complete resection have adopted different definitions for this issue: pathological proof of clear margin, 4 integration of the results of preoperative evaluations and intraoperative electrocorticography, 11 and removal of the entire cortex that elicited significant abnormalities on EEG studies. 19 We applied the last definition in this study, but assessment of completeness of resection by integrating clinical data could present some variability among the different institutions. The presence of the eloquent cortex within or close to the identified ictal onset zone is a frequently encountered situation in which incomplete resection is necessary. Although MST could be a viable option in this situation, the efficacy of this procedure is controversial. 11, 15 None of the 3 patients in our study who underwent MST combined with cortical resection became seizure free, although 2 of them exhibited a worthwhile improvement in seizure frequency. A more sophisticated definition of an ictal onset zone is required to achieve complete resection, especially in nonlesional epilepsy. Concordance of data from MR imaging, surface ictal EEG, and FDG-PET studies was a marginally significant prognostic variable for lesional epilepsy in our study. Concordance of evaluative data is an important prognostic variable in other studies. 20, 33 The use of new localizing modalities may enhance the ability to find an ictal onset zone in patients with discordant data. 25 In our study, we observed an actuarial rate of the running-down phenomenon of 10% in the 5th year after the first postoperative seizure. The running-down phenomenon, that is, the late remission of postsurgical seizures, is also a poorly understood process. 5 It reportedly occurs in 5-15% of patients receiving temporal lobectomy. 2, 9 Because the running-down phenomenon is not a rare event, it could be an important mechanism of seizure alleviation in patients with FCD in long-term follow-up.
Discontinuation of AEDs after successful epilepsy surgery is an interesting issue for clinicians. One of the aims of epilepsy surgery is to remove or at least lessen the harmful effects of AEDs on cognitive functions in children. An extended schedule of postoperative AED medication for more than 1 year seems to have no added benefit, and early tapering of AEDs may be safely initiated in seizure-free patients without raising the risk of seizure recurrence. 10, 28, 29 However, some researchers propose that deprivation of AEDs too early is the source of seizure recurrence. 28, 36 Tapering of AEDs after at least 10 months have elapsed from surgery has been recommended for mesial TLE. 21 However, there are limited data regarding this issue in patients with FCD. At present, the optimal time and speed of AED withdrawal after surgery remain to be individualized. The median time of 23 months to AED discontinuation in our study was obtained from purely retrospective analyses. A prospective protocol can be proposed (Fig. 5) . If a lesion is completely removed in patients with "nonintractable" epilepsy, AEDs can be tapered off soon after the surgery. However, it would be prudent to keep administering AEDs for at least 6 months after surgery in patients with intractable epilepsy to prevent seizure recurrence. After that, surface EEG readings should be checked. Tapering of AEDs can be tried if the patients have no seizures and normal EEG findings. The grace period may be extended to 1 year if surface EEG results are abnormal or if there is a residual lesion on postoperative MR imaging. For patients with postoperative seizures, tapering of AEDs should be individualized, usually with an extended medication schedule.
Conclusions
Epilepsy surgery in pediatric patients with FCD gave freedom from seizures to half of the carefully selected patients in the 1st year, but the proportion decreased to one-third in a long-term follow-up. The running-down phenomenon and repeat operation provide an additional opportunity of attaining seizure-free status, and almost one-half of all patients were eventually seizure free at their last follow-up. Because a complete resection of FCD has a strong prognostic implication for seizure control, a better method to define the extent of FCD is required to assist with resection, especially in nonlesional epilepsy. 
